For unreconstituted peptide products: Store in a cool, dry environment Avoid prolonged heat exposure Protect from direct sunlight Keep sealed when not in use After preparation, refrigeration may be preferred depending on research requirements
Ideal Candidate Profiles Adults with confirmed GH deficiency by stimulation testing Patients experiencing age-related GH decline Individuals with mild to moderate metabolic syndrome Contraindications and Precautions Active cancer or history of pituitary tumors Untreated thyroid disorders Pregnancy or breastfeeding Severe kidney or liver impairment Disclose all medical history and medications before starting sermorelin therapy
If sleep quality deteriorates, dose timing or total daily dose may need adjustment
Therapies enhancing GSH could become a cornerstone to reduce severity and fatal outcomes of inflammatory diseases and COVID-19 and increasing GSH levels may prevent and subdue these diseases
However, there are safety concerns researchers should consider before starting a study of this peptide
Pregnancy and Breastfeeding There is limited safety data regarding sermorelin use during pregnancy or breastfeeding
&srotate=0)
